SEC Filings

Form S-3
PROTAGONIST THERAPEUTICS, INC filed this Form S-3 on 09/07/2018
Document Outline
Entire Document (414.3 KB)
Subdocument 1 - S-3 - S-3
Page 1 - As filed with the Securities and Exchange Commission on September 6, 2018
Page 2 - The information contained in this prospectus is not complete and may be changed. We may not sell the
Page 3 - TABLE OF CONTENTS
Page 4 - PROSPECTUS SUMMARY
Page 5 - Janssen License and Collaboration Agreement
Page 6 - Company Information
Page 7 - The Offering
Page 8 - RISK FACTORS
Page 9 - N/A
Page 10 - USE OF PROCEEDS
Page 11 - SELLING STOCKHOLDERS
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - PLAN OF DISTRIBUTION
Page 16 - N/A
Page 17 - N/A
Page 18 - LEGAL MATTERS
Page 19 - INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
Page 20 - PART II
Page 21 - Item 16. Exhibits and Financial Statement Schedules
Page 22 - N/A
Page 23 - N/A
Page 24 - SIGNATURES
Page 25 - N/A
Subdocument 2 - EX-5.1 - EX-5.1
Page 1 - Exhibit 5.1
Page 2 - N/A
Subdocument 3 - EX-10.1 - EX-10.1
Page 1 - Exhibit 10.1
Page 2 - N/A
Page 3 - ARTICLE II.
Page 4 - N/A
Page 5 - ARTICLE III.
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - ARTICLE IV.
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - ARTICLE V.
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Subdocument 4 - EX-23.1 - EX-23.1
Page 1 - Exhibit 23.1
Page 2 - N/A